PharmaVOICE Podcasts

Podcast Overview

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 30 Oct 2009 13:28:42 PDT

A 5-minute overview on Podcasts.

http://www.zentation.com/viewer/index.php?passcode=vZyD7tfRw5

Learn how PharmaVOICE produces, promotes, and distributes podcasts, and how to maximize exposure for your thought leaders to the pharmaceutical industry.

The Evolution of the E-Patient

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 13 Oct 2009 09:57:18 PDT

Date: 10/01/2009

Length: 00:20:13

Size: 9.25MB

Thought Leader: Bonnie Brescia, Founding Principal, BBK Worldwide

Ms. Brescia provides an overview of the e-patient, how this special patient population can be leveraged for clinical trial participation, and how social media are impacting recruitment and clinical research.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Return On Investment in Patient Recruitment

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 01 Sep 2009 07:16:14 PDT

Date: 09/01/2009

Length: 00:22:47

Size: 10.4MB

Thought Leader: Richard Malcolm Ph.D., CEO, Acurian

Dr. Malcolm talks about planning and measuring return on investment in patient recruitment today, as well as what the future holds in this area.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Commercial Operations Outsourcing: A Leading-edge Response to the Financial Storm Affecting the Life-sciences Industry

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 01 Sep 2009 07:13:48 PDT

Date: 08/01/2009

Length: 00:17:26

Size: 12.31MB

Thought Leaders: Jassi Chadha, Head of Analytics Practice, Cognizant, Patrick Brundage, Practice Leader, Life Sciences Analytics, Cognizant, and Nagaraja Srivatsan, VP and Head of Life Sciences, North America, Cognizant

In this special PharmaVOICE 100 podcast, our thought leaders discuss the current state of the life-sciences industry, the changes it is experiencing now, and what the industry will look like in the next decade.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

The Digital Wave – Delivering Education and Services to Healthcare Providers

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 01 Sep 2009 07:08:43 PDT

Date: 08/01/2009

Length: 00:11:50

Size: 5.41MB

Thought Leader: Donato Tramuto, CEO and Vice Chairman, Physicians Interactive

In this special PharmaVOICE 100 podcast, Mr. Tramuto discusses digital technologies that educate and provide important services to healthcare providers to improve communication and help deliver better patient outcomes.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

The State of Women in Healthcare

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 01 Sep 2009 07:12:31 PDT

Date: 08/01/2009
Length: 00:16:53
Size: 7.75MB

Thought Leader: Laurie P. Cooke, R.Ph., CEO, Healthcare Businesswomen's Association (HBA)

In this special PharmaVOICE 100 podcast, Ms. Cooke outlines the current state of women in healthcare, discusses the importance of mentoring, and shares her views on volunteerism. This episode also provides an overview of the HBA and its upcoming Annual Leadership Conference — Limitless Leadership: Bridging Today, Tomorrow, and Beyond — in November 2009.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Science is Greater than the Economy

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 09 Jun 2009 09:16:27 PDT

Date: 05/29/2009
Length: 00:11:46
Size: 5.38MB

Thought Leaders: Lawrence Reiter, Ph.D., Director of Global Affairs, Criterium Inc.

Dr. Reiter discusses why it’s important to maintain R&D spending during fiscally challenging times, the pros and cons of a global R&D plan, how to do more with less, what technology brings to the table, and other critical factors to improve the development process.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Charting a New Course by Catalyzing Transformation

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 09 Jun 2009 09:15:08 PDT

Date: 05/28/2009
Length: 00:14:56
Size: 6.84MB

Thought Leaders: Adrian McKemey, Ph.D. Managing Director, Quintiles Consulting
Michael Arlotto, Ph.D., Senior Vice President, Quintiles Corporate Development.

In episode three, of a three-part series, “Surviving to Thriving in Stormy Weather,” our thought leaders discuss declining R & D productivity combined with increasing development costs. They offer insights and solutions to maximizing efficiencies and effecting change within R & D organizations in the biopharma industry.

Play Podcast

Download Related Whitepaper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

How to Connect Patients and Physicians Around Your Brand

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 09 Jun 2009 09:12:11 PDT

Date: 05/27/2009
Length: 00:17:57
Size: 8.22MB

Thought Leaders: Michael Ball, Ph.D., VP of Marketing, InfoMedics
Paul LeVine, VP of Analytical Services, InfoMedics

In this episode, Dr. Ball and Mr. LeVine discuss the importance of patient feedback – how to obtain it and how it can be used to better connect brands with patients and physicians in a practice setting.

Play Podcast

Download Related Whitepaper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Connecting through Electronic Health Records

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 09 Jun 2009 09:08:52 PDT

Date: 05/26/2009
Length: 00:14:41
Size: 6.72MB

Thought Leaders: Landen Bain, Liaison to Healthcare, CDISC
Dave Iberson-Hurst, VP of Technical Strategy, CDISC

In this episode, Mr. Bain and Mr. Iberson-Hurst discuss CDISC’s efforts in instituting standards for Electronic Health Records and RFD - Retrieve Form for Data Capture. They also cover where the organization’s efforts will be applied in the future.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Making Headway in Shifting Winds by Maximizing Value

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 09 Jun 2009 09:06:55 PDT

Date: 5/01/2009
Length: 00:19:08
Size: 8.76MB

Thought Leaders: James Featherstone, Ph.D., VP of Product Development and Commercialization for the EU, Quintiles Consulting, Bruce E. Johnson, Ph.D., Senior Research Director, Eidetics, a division of Quintiles Consulting, and Heidi Hunter, Global VP, Business Development, Quintiles

In episode two, of a three-part series, "Surviving to Thriving in Stormy Weather," our thought leaders discuss new commercialization processes as healthcare moves towards personalized medicine. They also cover how to assess market potential for personalized therapies, post-launch sales strategies for niche drugs, and finally, meeting the needs of global and regional markets for these types of therapies.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Better Standards and Metrics for CROs and Sponsors

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 30 Apr 2009 07:43:40 PDT

Date:4/08/2009
Length: 00:14:29
Size: 6.63MB
Thought Leaders:
Gregg Dearhammer, President, i3 Statprobe
Karen Goss, Global Director, Pharmacovigilance, i3 Drug Safety

In this episode, Mr. Dearhammer and Ms. Goss discuss the need for metrics and standards for clinical trials management and the impact of the Metrics Champion Consortium (MCC) on CROs and sponsors.

Play podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Setting Sail for Success by Optimizing Productivity

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 02 Apr 2009 08:20:31 PDT

Date:4/01/2009
Length: 00:14:31
Size: 6.64MB

Thought Leaders: Michael Hagan, Principal Consultant, Quintiles Consulting and James C. Kirk, VP and Practice Leader, Eidetics, Quintiles Consulting

In episode one, of a three-part series, “Surviving to Thriving in Stormy Weather,” Mr. Hagan and Mr. Kirk discuss market pressures and how economic turmoil in the biopharma industry can be overcome by using process optimization.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Overcoming Global Marketing and Regulatory Challenges

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 12 Mar 2009 06:51:28 PDT

Date:3/02/2009
Length: 00:012:37
Size: 5.77MB

Thought Leaders: John Doyle Dr.P.H., Managing Director and Practice Leader, Market Access, Quintiles Consulting, and Geoff Garabedian, Managing Director and Practice Leader, Regulatory, Quintiles Consulting

In this episode, Dr. Doyle outlines cost-based evaluation and market-access strategies based on comparative effectiveness and safety research. Then Mr. Garabedian talks about the impact of regulatory globalization, and finally, there is a discussion covering the latest pharmaceutical initiatives from the European Commission, and how these will impact the global healthcare industry.

Play P0dcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Global Clinical Trials Outsourcing: New Tips and Trends

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 12 Mar 2009 06:50:01 PDT

Date:3/02/2009
Length: 00:012:25
Size: 5.68MB

Thought Leader: Patrick Durbin, VP, Fisher Clinical Services (a division of Thermo Fisher Scientific)

In this episode, Mr. Durbin offers some best practices for developing a strategic partnership with outsourcing providers, discusses some of the biggest challenges and missteps in global clinical trials outsourcing, covers emerging opportunities at the global level, and lists some of the most important emerging trends in this arena.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Driving Sales Force Effectiveness in Turbulent Times

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 12 Mar 2009 06:48:48 PDT

Date:2/23/2009
Length: 00:011:51
Size: 5.42MB

Thought Leader: Brett Knowles, Founder, Performance Measurement and Management

In this episode, Mr. Knowles discusses an actionable approach to boosting sales force performance, and how it has delivered results for Pharmaceutical companies in today's challenging environment.

Free Whitepaper Paper for download: Five Steps to Pharma Sales Force Effectiveness Click Here

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Pharmaceutical Forecasting Insights: The Process, Hurdles, and Important Trends

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 12 Mar 2009 06:46:38 PDT

Date:1/30/2009
Length: 00:013:28
Size: 6.16MB

Thought Leader: Todd Johnson, Director of Forecasting, MattsonJack

In this episode, we discuss the importance and benefits of having an effective forecasting process, hurdles to implementation, available tools, and trends in the forecasting arena, particularly oncology forecasting. MattsonJack is holding a live workshop on forecasting in Scottsdale, AZ March 19-20. The workshop offers best practices, real-world tips and expert advice. To learn more about this important event Click Here.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

John Crowley’s Personal Crusade

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 12 Mar 2009 06:44:26 PDT

Date:12/30/2008
Length: 00:07:18
Size: 3.34MB

Thought Leader: John Crowley, President and CEO, Amicus Therapeutics

In this episode, Mr. Crowley shares his personal journey to find viable treatements for Pompe disease, a condition which two of his children are afflicted. His amazing story is also showcased in the January issue of PharmaVOICE.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Understanding the New PhRMA Code for Medically Relevant Items

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 12 Mar 2009 06:42:29 PDT

Date:12/30/2008
Length: 00:13:00
Size: 5.95MB

Thought Leader: David Ganz, Managing Director, Total Health Rewards

In this episode, Mr. Ganz discusses the new PhRMA code as it relates to medically relevant items (MRIs) and how companies can stay compliant with this new guideline.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Critical Care Opportunities in a Global Arena

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 12 Mar 2009 06:39:58 PDT

Date:12/15/2008
Length: 00:12:05
Size: 5.50MB
Thought Leader: Clive Meanwell, M.D., PhD., Chairman and CEO, The Medicines Company

In this episode we talk about moving from a US focused to a globally focused company. We discuss several factors impacting the global pharmaceutical and healthcare market, and how outcomes research will be used in the future in the US and ex-US

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

Demystifying Social Media — It's Not About Controlling the Message

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 05 Dec 2008 08:10:54 PST

Date:11/19/2008
Length: 00:11:56
Size: 5.46MB
Thought Leader: Ken Ribotsky, President and CEO, Core-Create

In this episode, Mr. Ribotsky discusses the relatively new web phenomenon called Social Media – what it is and how it can be used for improving brand messaging and communications.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

Achieve Optimal Messaging for Your Inline Brand

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 05 Dec 2008 08:09:31 PST

Date:11/19/2008
Length: 00:16:21
Size: 7.48MB
Thought Leader: Ian McKinnon Ph.D., Senior Vice President, TNS Healthcare

In this episode, Dr. McKinnon discusses how brand teams can optimize their messages, evaluate their messengers (sales reps), and minimize the damage from competing messages in their market space.

Play Podcast

Download Related Presentation

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

The Benefits and Challenges of Creating Personalized Brand Dialogue Between Physicians and Patients

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 05 Dec 2008 08:07:26 PST

Date:11/19/2008
Length: 00:17:28
Size: 8.00MB
Thought Leaders: Paul LeVine, VP Analytical Services, InfoMedics and Dr. Stanley Wulf, Chief Medical Officer, InfoMedics

In this episode, Mr. LeVine and Dr. Wulf discuss ways to improve the dialog between physicians and patients using personalized data and communication tools in an effort to increase patient retention and health outcomes.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

Procuring and Managing Clinical Staffing Resources

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 05 Dec 2008 08:01:15 PST

Date:11/19/2008
Length: 00:15:03
Size: 6.89MB
Thought Leader: Stephen Cottrell, Executive V.P. of Operations and Business Development, inVentiv Clinical Solutions

In this episode, Mr. Cottrell outlines many of the challenges in procuring and managing clinical staffing resources, and offers advice on how to overcome them.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

Ensuring Launch Success: Payer and Prescriber Considerations in

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 05 Dec 2008 07:56:19 PST

Thought Leader: Sarah Rickwood, Senior Principal, IMS

Play Podcast

Link to Related Videocast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

Fresh Approaches to Launch Success

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 05 Dec 2008 07:58:58 PST

Thought Leader: Robert Harold, Senior Principal, IMS

Play Podcast

Link to Related Videocast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

Winning in the Dynamic Market: Novel Approaches

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 05 Dec 2008 06:43:30 PST

Thought Leader: Lisa Morris, Global APLD Services, IMS

Play Podcast

Link to Related Videocast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

The Dynamic Market: Why It's the Most Important Area of Focus for Your Brand

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 05 Dec 2008 07:49:48 PST

Changing the Game: New Opportunities in the Dynamic Market

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 05 Dec 2008 06:40:50 PST

A Dual-Degree MSPharm/MBA Online Program Update

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 05 Dec 2008 06:36:08 PST

Date:10/17/2008
Length: 00:07:52
Size: 3.60MB
Program Representative: David B. Brushwood, R.Ph., J.D., Professor of Pharmaceutical Outcomes and Policy, University of Florida

In this episode, Professor Brushwood provides an update on a new online dual-degree program: a Master of Science in Pharmacy degree from the University of Florida and a Master of Business Administration from Stetson University. He discusses the benefits of the dynamic dual-degree, the program structure, the advantages of an online program, and admission requirements. Current registration period ends after November 1, 2008.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

eClinical Moves into the Mainstream

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 29 Sep 2008 12:54:57 PDT

Date:9/11/2008
Length: 00:13:28
Size: 6.17MB

Thought Leader: Stacey Arrambide, VP, Statistics and Data Management, inVentiv Clinical Solutions

In this episode, Stacey Arrambide shares her insights about the eClinical arena -- how it has evolved and what the benefits are, particularly regarding cost savings.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

Fighting Back: Technology Solutions to the Counterfeit Drug Problem

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 29 Sep 2008 12:56:21 PDT

Date: 9/22/2008
Length: 00:15:56
Size: 7.29MB
Thought Leader: MaryAnn Hegedus, Business Development Manager, Colorcon

In this episode, Ms. Hegedus discusses the implications of the counterfeit drug market, and offers insights on how companies can use authentication technologies to protect their revenue, enable security throughout the entire supply chain at the dosage level, and improve consumer confidence.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

The Pharma-Physician-Patient Connection: Working Together to Improve Treatment Outcomes

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 29 Sep 2008 12:52:14 PDT

Date: 9/8/2008
Length: 00:14.49
Size: 6.78MB

Thought Leaders:
Dr. Stanley Wulf, Chief Medical Officer, InfoMedics
Ray Bullman, Executive VP of NCPIE (National Council on Patient Information and Education)

In this episode, our thought leaders share insights on improving treatment outcomes through patient adherence programs, including best practices and a look into the future of adherence programs.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Molecular Design and the Critical Path Problem

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 11 Sep 2008 07:35:12 PDT

Date:9/08/2008
Length: 00:16:35
Size: 7.59MB

Thought Leader: Stephen Byrn, Ph. D., Charles B. Jordan Professor of Medicinal Chemistry and Head of the Department of Industrial and Physical Pharmacy, Purdue University; and Head of the Aptuit Scientific Advisory Board

In this episode, Dr. Byrn speaks about the critical path problem in drug development and how a designed molecular delivery system can improve the drug development process.

Play Podcast

Download free related whitepaper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

E-Clinical: Driving Efficiencies and Reducing Costs for Drug Development

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 11 Sep 2008 07:37:29 PDT

Date:7/30/2008
Length: 00:16:44
Size: 7.66MB
Thought Leader: Chris Porter, Cofounder and Chief Operating Officer, Clinipace

In this episode, Taren Grom, Editor, PharmaVOICE, speaks with 2008 PharmaVOICE 100 honoree Chris Porter about the need for a better clinical model, one driven by affordable technology and software solutions, as well as best practices to improve clinical research processes.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Insights on Developing a Career Path in the New Era of the Life Sciences

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 11 Sep 2008 07:38:20 PDT

Date:7/30/2008
Length: 00:15:08
Size: 6.93MB
Thought Leader: Howard Weisman, CoFounder, CEO, and Chairman, EKR Therapeutics Inc.

In this episode, Taren Grom, Editor, PharmaVOICE, speaks with Mr. Weisman, a 2008 PharmaVOICE 100 honoree, about how to maximize career opportunities in the pharmaceutical industry and how the career paths are changing.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Mobile Devices: Connecting Physicians and Pharma

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 11 Sep 2008 07:41:05 PDT

Date:7/15/2008
Length: 00:10:38
Size: 4.87MB
Thought Leader: Sandeep Shah, President and Founder, Skyscape

In this episode, Taren Grom, Editor, PharmaVOICE, speaks with Mr. Shah about the importance of wireless mobile devices to physicians and how pharmaceutical companies can leverage this platform for physician communications.Free Report: Effect of PDA-Based Information on Treatment Decisions

Play Podcast

Download Related Free Report

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Patient Journey Marketing™ and the Power of Video

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 11 Sep 2008 07:39:21 PDT

Date:7/8/2008
Length: 00:17:52
Size: 8.32MB
Thought Leader: Liz Kay, VP, Account Services, Healthcare Practice, Cramer

In this episode, Liz Kay discusses the use of online video as an effective and interactive medium for patient communications.Whitepaper: How Patient Journey Marketing™ delivers more value to your customers and your bottom line

Play Podcast

Download Related White Paper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Improving Clinical Operations at AstraZeneca

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 12 Sep 2008 06:31:43 PDT

Date:6/27/2008
Length: 00:16:09
Size: 7.39MB
Thought Leader: Karen Gotting-Smith, Ph.D. VP, Business Performance and Continuous Improvement, AstraZeneca Pharmaceuticals

Taren Grom, CoFounder and Editor-in-Chief of PharmaVOICE talks with Dr. Gotting-Smith about current market factors driving change in clinical operations, outsourcing considerations, new technologies and advances in data management.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

A Dual-Degree MSPharm/MBA Online Program for Life-Sciences Professionals

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 12 Sep 2008 06:33:47 PDT

Date:6/16/2008
Length: 00:09:10
Size: 4.2MB
Thought Leader: David B. Brushwood, R.Ph., J.D., Professor of Pharmaceutical Outcomes and Policy, University of Florida

In this episode, Professor Brushwood provides an overview of a new online dual-degree program: a Master of Science in Pharmacy degree from the University of Florida and a Master of Business Administration from Stetson University. He discusses the benefits of the dynamic dual-degree, the program structure, the advantages of an online program, and admission requirements.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Stiefel’s Dedication to Corporate Philanthropy

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 12 Sep 2008 06:35:33 PDT

Date: 6/19/2008
Length: 00:10:59
Size: 5.09MB
Thought Leader: Lyra Myers, Senior Global Category Manager, Stiefel Laboratories

In this episode, Taren Grom, Editor of PharmaVOICE, speaks with Lyra Myers about Stiefel’s many activities in corporate philanthropy, as well as her personal commitment to worthy causes.
Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Amgen’s Commitment to Philanthropy

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 12 Sep 2008 06:36:28 PDT

Date:6/13/2008
Length: 00:08:46
Size: 4.01MB
Thought Leader: Eduardo Cetlin, Senior Manager of Corporate Contributions, Amgen

In this special episode, Taren Grom, Editor of PharmaVOICE, speaks with Eduardo Cetlin, who discusses the Amgen Foundation, how Amgen encourages employees to become involved in volunteerism, his favorite service endeavors, and the overall goal of Amgen's philanthropic efforts.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

A Personal Dedication to Volunteerism and Mentoring

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 12 Sep 2008 06:37:31 PDT

Date:6/13/2008
Length: 00:12:44
Size: 5.82MB
Thought Leader: Sherrie Pietranico, Ph.D., Research Leader, Roche

In this special episode, Taren Grom, Editor of PharmaVOICE, speaks with Dr. Pietranico about her volunteer activities educating elementary school children about science, and how the Roche internship program helped one student become a successful scientist in the pharmaceutical industry.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Making Pharmacovigilance Work: Key steps for implementing a proactive, business-critical safety model

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 12 Sep 2008 06:38:32 PDT

Date: 6/5/2008
Length: 00:06:39
Size: 3.04MB

Thought Leader: Uwe Maennl, M.D., Ph.D., VP and Worldwide Head of Pharmacovigilance, PAREXEL International and Gadi Saarony, Corporate VP and Worldwide Head, PAREXEL Consulting

In this episode, Dr. Maennl and Mr. Saarony discuss a new safety model for pharmacovigilance, including risk management, key stakeholders, and performance benchmarks to this new approach.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Redefining the CRO

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 12 Sep 2008 06:39:50 PDT

Date: 5/7/2008
Length: 00:13:29
Size: 6.17MB

Thought Leader: Bob Burford Ph.D., Managing Director, Aptuit Consulting

In this episode, we discuss the relationship between drug developers and CROs, including current market conditions, the changing needs of drug developers, how to choose an outsourcing provider, expectations of a CRO, and the future of this important relationship.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Counter-Launch Planning: Pre-empting and Protecting Against Competitive Product Launches

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 12 Sep 2008 06:41:19 PDT

Date: 5/6/2008
Length: 00:10:33
Size: 4.83MB

Thought Leader: Stan Bernard, M.D., MBA, President, Bernard Associates LLC

Dr. Bernard discusses the underutilized concept of Counter Launch Planning (CLP) for protecting an established brand, including what it is, why it's important, who participates in the process, how it differs from traditional marketing and war games, and finally, important execution considerations.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Precommercial Marketing and Planning: Securing Future Success through Meaningful Differentiation

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 12 Sep 2008 06:42:52 PDT

Date: 4/30/2008
Length: 00:10:58
Size: 5.02MB

Thought Leader: Laurie Lucas, Founder and Principal, L3 Healthcare Marketing LLC

This Podcast covers several issues related to starting the marketing sequence earlier in the development cycle, including the differences between precommercial marketing and traditional product marketing, who the stakeholders are, what the necessary activities are, and some best practices for these activities.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Making it Stick – How Can Patient Education Really Make a Difference

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 12 Sep 2008 06:45:00 PDT

Date: 4/30/2008
Length: 00:11:50
Size: 5.42MB

Thought Leaders: Dr. Stanley Wulf, Chief Medical Officer, InfoMedics, and Ray Bullman, Executive VP of NCPIE (National Council on Patient Information and Education)

This Podcast covers several key issues related to patient education and patient adherence, including who the key players are, what they can do to improve patient education, and what the pharmaceutical companies can do to raise the effectiveness of patient education.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Late-Phase Research Success: Leveraging Secondary Data

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 12 Sep 2008 06:46:24 PDT

Date: 4/28/2008
Length: 00:16:02
Size: 7.34MB

Thought Leader: Cyndi Verst, Pharm.D., M.S., Senior VP, Global Late Phase, i3 InnovusThis Podcast covers the benefits of blending scientific and commercial objectives in late-phase research — saving time and money — the use of specialized data assets, the challenges of leveraging secondary data assets, and what is in store for late-phase research in the near future.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Enhancing Global Market Access Strategies with Named Patient Programs

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 12 Sep 2008 06:47:31 PDT

Date: 4/23/2008
Length: 00:12:14
Size: 5.60MB

Thought Leaders: John Lagus, VP of Business and Corporate Development, IDIS

This final installment in a three-part series covers how named patient programs can be used for market development, assist with regulatory challenges, address reimbursement issues, and develop key opinion leaders, and more.

Play Podcast

Free Whitepaper Download: "Enhancing Global Market Access Strategies with Named Patient Programs"
Download RelatedWhite Paper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

The Future of Pharma CRM

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 12 Sep 2008 08:28:10 PDT

Date: 4/22/2008
Length: 00:15:43
Size: 7.19MB

Thought Leader: Matt Wallach, VP Sales and Marketing, Verticals onDemand, Inc.

This podcast covers the changing pharmaceutical sales and marketing model and the tools and solutions that are needed to shape the future of salesforces.

Play Podcast

Free Whitepaper Download: "Getting SaaSy In Pharma: How SaaS CRM Technology Today's Beleaguered Pharmaceutical Companies."
Download Related White Paper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Silo Busting – New Approaches to Brand Development

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 12 Sep 2008 06:49:35 PDT

Date: 4/2/2008
Length: 00:09:13
Size: 4.21MB

Event Representative: Camille DeSantis, BS, MT (ASCP), Copresident & Managing Partner, Brand Strategy & Client Services, Guard Dog Brand Development LLC

This Podcast covers how brand development agencies and life-sciences companies can partner to achieve optimal results, including breaking down the silos between disciplines. We also cover market research and brand identity ROI, and how to handle soft measurables. And, finally, Ms. DeSantis provides three best practices that can be employed to improve brand value through communications.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Training Seminar: Medical Education for Pharmaceutical Professionals: Information, May 6, 2008

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 01 Apr 2008 07:08:46 PDT

Date: 3/20/2008
Length: 00:06:37
Size: 3.03MB

Event Representative: Dr. Paul M. Krueger, Associate Dean for Academic Affairs, at the UMDNJ School of Osteopathic Medicine in New Jersey

Dr. Krueger provides an overview of an upcoming, day-long seminar focused on the diagnosis and treatment of medical disorders: Fundamentals of Clinical Practice. This is the first in a series of instructional forums called Medical Education for Pharmaceutical Professionals, also known as MEPP. The first seminar will be held May 6, 2008, in New Jersey.

For seminar information and registration, click here.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

The Unique Challenges and Opportunities in Emerging Markets: Seizing Potential in the New High-Growth Countries

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 03 Mar 2008 07:01:21 PST

Date: 2/26/2008
Length: 00:16:29
Size: 7.55MB

Thought Leader: Stephen Potts, Regional Director for Healthcare – Asia Pacific, the Middle East and Africa, TNS Healthcare

Opportunities in emerging markets are numerous and challenging. This episode provides vital information on maximizing opportunities in the BRIC markets as well as the N-11 countries.

Play Full Podcast

Download Related Presentation

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Regulatory Concerns in Named Patient Programs

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 03 Mar 2008 07:03:12 PST

Date: 2/19/2008
Length: 00:15:01
Size: 6.87MB

Thought Leader: Maria Kempshall, Head of Regulatory Affairs and Quality Assurance, IDIS

This is the second of three IDIS sponsored Podcasts covering named patient programs. In this episode, Ms. Kempshall gives a brief overview on the topic and then provides a detailed discussion on key regulatory issues, factors impacting pharmacovigilance, and finally, how to communicate the availability of a named patient program.

Play Full Podcast

Download Related Article

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Navigating the Formulary Market

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 13 Feb 2008 06:34:25 PST

Date: 2/1/2008
Length: 00:14:26
Size: 6.60MB

Thought Leader: Jeff Thomas, President, inVentiv Strategy & Analytics

In this episode, Mr. Thomas discusses ways to develop effective formulary plans for new drugs and existing drugs with new indications, how to identify formulary opportunities, ways to use competitive intelligence in the plan development process, how brand managers can avoid common mistakes, and the best ways to communicate a plan to formulary decision makers.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Named Patient Programs: An Overview

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 03 Mar 2008 07:01:49 PST

Date: 2/5/2008
Length: 00:18:17
Size: 8.37MB

Thought Leader: Natalie Douglas, CEO, IDIS

In this episode, Natalie Douglas provides an introduction to named patient programs, describes the factors that motivate pharmaceutical and biotech companies to implement these programs, and highlights the benefits to the patient as well as the sponsoring company.

Play Full Podcast

Download Related White Paper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

MSLs: An Evolving Specialty

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 05 Feb 2008 07:23:08 PST

Date: 1/24/2008
Length: 00:09:58
Size: 4.56MB

Thought Leader: Robin L. Winter-Sperry, M.D., President and CEO of Scientific Advantage LLC and MSL Advantage LLC

In this episode, Dr. Robin Winter-Sperry, President and CEO of Scientific Advantage LLC and MSL Advantage LLC, talks about the evolving role of the medical science liaison (MSL), return on education, how MSLs are improving patient outcomes, the growing trend of the inclusion of MSLs by emerging companies, and best practices for MSLs working in virtual teams.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Own It: Transforming Public Perception of Pharma through Better Sales & Marketing Practices

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 26 Nov 2007 12:11:58 PST

Date: 11/14/2007
Length: 00:12:40
Size: 5.79MB

Thought Leaders: Michael Ball, Ph.D., VP, Marketing and Product Management, InfoMedics, and Paul LeVine, VP, Analytical Services, InfoMedics

In this episode, Dr. Ball and Mr. LeVine talk about three key areas of brand management: public perception, principal stakeholders, and technology in sales and marketing practices.

Play full podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Precommercial Marketing and Planning: Laying the Ground Work for Future Success

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 30 Oct 2007 13:07:55 PDT

Date: 10/23/2007
Length: 00:14:53
Size: 6.81MB

Thought Leader: Laurie Lucas, Founder and Principal, L3 Healthcare Marketing

Ms. Lucas provides details on how to develop an informed view of the market for your brand during the precommercialization phase. The discussion covers the risks for not doing so, the benefits of a prelaunch strategy, and the tactics for ultimate success.

Play Full Podcast

Download the whitepaper (Requires Acrobat PDF Reader)

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Competitive Simulations: The New, Improved War Games

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 10 Sep 2007 04:55:53 PDT

Date: 9/7/2007
Length: 00:12:57
Size: 5.93MB
Thought Leader: Stan Bernard, M.D., MBA, President, Bernard Associates LLC

Dr. Bernard highlights the differences between competitive simulations and traditional business war games and discusses how customized competitive simulation exercises can provide strategic advantages for pharmaceutical brands and brand teams.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

The Brave New Real World: A Changing Paradigm for Documenting Product Value and Safety Postapproval

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 30 Aug 2007 08:42:12 PDT

Date: 8/29/2007
Length: 00:15:30
Size: 6.96MB

Thought Leader: Jeff Trotter, Senior VP, Lifecycle Sciences Group, Icon Clinical Research

Jeff Trotter speaks about the need for real-world value and safety in postmarketing research, the current landscape, designing new studies, and how the industry can leverage opportunities in the postapproval environment.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

ePRO's Impact on Clinical Trials

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 30 Aug 2007 08:35:39 PDT

Date: 8/27/2007
Length: 00:12:14
Size: 5.60MB
Thought Leader: Jean Paty, Ph.D., Founder and Senior VP, Scientific, Quality and Regulatory Affairs, invivodata

Dr. Paty talks about a defining moment in clinical trial data, how ePRO will revolutionize clinical trials, improving the adoption of ePRO, and the future of clinical data technology.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Incorporating Electronic Health Records in the Trial Process

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 30 Aug 2007 08:36:13 PDT

Date: 8/27/2007
Length: 00:17:54
Size: 8.19MB

Thought Leader: James Rogers, CEO, Nextrials Inc.

Taren Grom, Cofounder and Editor of PharmaVOICE magazine, and James Rogers, CEO of Nextrials, discuss the benefits of incorporating electronic health records (EHR) into the clinical-trial process, what the challenges are, and how EHR can be used in other areas, such as patient recruitment.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Early Adopters Using SAFE Digital Signatures

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 17 Aug 2007 13:51:01 PDT

Date: 6/19/2007
Length: 00:6:49
Size: 3.12MB
Thought Leader: Mollie Shields-Uehling, President and CEO, SAFE Biopharma Association

Dan Limbach, Producer, PharmaVOICE Webcast Network, speaks with Mollie Shields-Uehling, who provides an overview of the SAFE digital signature technology, the benefits of electronic submissions, and which companies are adopting this model.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Trends in Patient Recruitment

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 17 Aug 2007 13:49:08 PDT

Date: 6/19/2007
Length: 00:5:50
Size: 2.67MB

Thought Leader: Bonnie Brescia, Cofounder, BBK Worldwide

Taren Grom, Cofounder and Editor of PharmaVOICE, speaks with Bonnie Brescia about the changing role of the pharmaceutical company in patient recruitment.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Managing Chargebacks to Boost the Bottom Line

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 17 Aug 2007 13:35:27 PDT

Date: 8/17/2007
Length: 00:19:23
Size: 8.87MB

Thought Leader: Al Godley, Director of Life-Science Solutions, Edge Dynamics

Al Godley explains the impact that chargebacks have on manufacturers' bottom lines, why chargebacks continue to be a source of silent revenue leakage, and best practices for chargeback management.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Improving Patient Compliance Using Ethnographic Research

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 13 Aug 2007 07:03:34 PDT

Date: 7/26/2007
Length: 00:15:21
Size: 7.02MB
Thought Leader: Stuart Paul, CEO, Communication Science Inc.

Stuart Paul outlines an innovative model that uses ethnographic research and evidence-based communications to achieve better health outcomes.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Translational Connection Model for Creating Infectious Disease Therapies: Part 1

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 13 Aug 2007 07:04:04 PDT

Date: 8/10/2007
Length: 00:16:49
Size: 7.70MB

Thought Leader: Barry Eisenstein, M.D., Senior VP, Scientific Affairs, Cubist Pharmaceuticals

Taren Grom, Cofounder and Editor of PharmaVOICE, and Dr. Eisenstein discuss the concept of a "translational connection" development model and how this shift in thinking can be employed to create new therapies to address unmet medical need in infectious disease in Part 1 of a 2-part series.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Translational Connection Model for Creating Infectious Disease Therapies: Part 2

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 13 Aug 2007 07:04:13 PDT

Date: 8/10/2007
Length: 00:16:10
Size: 7.40MB

Thought Leader: Barry Eisenstein, M.D., Senior VP, Scientific Affairs, Cubist Pharmaceuticals

Taren Grom, Cofounder and Editor of PharmaVOICE, and Dr. Eisenstein discuss how the "translational connection" model can be used in other therapeutic areas and where the next generation of medical/research talent will come from. Part 2 of a 2-part series.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Phase IV Registries and Patient Outcomes

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 13 Aug 2007 07:06:05 PDT

Date: 7/31/2007
Length: 00:14:00
Size: 6.41MB

Thought Leader: Nancy Dreyer, MPH, Ph.D., Chief of Scientific Affairs, Outcome

Dr. Nancy Dreyer discusses her involvement in the development of the Registries for Evaluating Patient Outcomes handbook published by the Agency for Healthcare Research and Quality and what some of the significant findings were from the research and how these data can positively impact patient outcomes.

Play Full Podcast

test

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Relationship Networking and Monitoring the Influence of Physicians

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 13 Aug 2007 07:04:36 PDT

Date: 7/24/2007
Length: 00:13:42
Size: 6.27MB
Thought Leader: Kelly Myers, CEO, Qforma Inc.

Kelly Myers discusses the concept of relationship networking, what the differences are between an action leader and a thought leader, and how tools from the field of physics can be used to study physician-based data to improve sales and marketing efficiency.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Reintegrating Healthcare and Society

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 13 Aug 2007 07:04:48 PDT

Date: 7/24/2007
Length: 00:13:48
Size: 6.32MB
Thought Leader: Laurie Myers, Ph.D., VP and Client Partner, Business Consulting, Fair Isaac Corp.

Dr. Laurie Myers talks frankly about the bond between healthcare and society and the challenges associated with strengthening this bond moving forward.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

EDC and the E-Clinical Space

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 26 Jul 2007 10:46:07 PDT

Date: June 2007
Length: 00:12:14
Size: 5.60MB

Thought Leader: Ronald Kershner, Ph.D., Senior VP, Clinical Operations, inVentiv Clinical Solutions LLC

Dr. Kershner outlines the current state of play of EDC in the industry and the benefits the technology can bring to clinical studies, particularly access to real-time data and cost savings. Dr. Kershner also provides his insights to remaining adoption challenges.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Why Validate?

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 26 Jul 2007 10:47:14 PDT

Date: June 2007

Length: 00:11:39
Size: 5.33MB

Thought Leader: Chris Biddle, VP, Solutions Architecture, GHX Pharma Solutions

Good data validation practices for managed care can make a big impact on a pharmaceutical company's bottom line. This episode covers several important issues on this topic, including the general business environment for validation, why validation is important, Medicare Part D ramifications, primary causes of data errors, the ROI of validation, and more.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Biological Drug Development

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 26 Jul 2007 10:47:56 PDT

Date: June 2007

Length: 00:5:13
Size: 2.39MB

Thought Leader: William J. Newell, Executive VP, Aerovance

Mr. Newell discusses the uses of biologics in the development of asthma treatments, the challenges involved with biologic drug development, and considerations when designing a trial.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Biotechnology Business Trends

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 26 Jul 2007 10:48:42 PDT

Date: June 2007

Length: 00:6:19
Size: 2.89MB

Thought Leader: Kenneth C. Carter, Ph.D., President and CEO, Avalon Pharmaceuticals

Dr. Carter talks about technology trends in the emerging biotechnology space, deal-making at the preclinical level, and Avalon's technology, a high-throughput discovery and development engine that is based on the total breadth of a cell's response at the genomic level to a drug.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Seed Funding

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 26 Jul 2007 10:49:12 PDT

Date: June 2007
Length: 00:3:41
Size: 1.68MB

Thought Leader:Barbara Schilberg, CEO, BioAdvance, Biotechnology Greenhouse of SE Pennsylvania

Ms. Schilberg discusses why it's important to invest in a new generation of life-sciences companies and how her organization is addressing a national problem — the gap in seed funding.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Global Biotechnology Trends

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 26 Jul 2007 10:51:00 PDT

Date: June 2007
Length: 00:4:26
Size: 2.03MB

Thought Leader:Martyn Postle, Chairman and Chief Executive, Cambridge Healthcare & Biotech Ltd.

In this Podcast episode, Mr. Postle provides a top-line overview of global biotechnology trends based on results from a recent report — U.K. Drug Pipeline —completed by Cambridge Healthcare & Biotech.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Partnerships and Funding Opportunities

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 26 Jul 2007 10:52:04 PDT

Date: June 2007
Length: 00:5:09
Size: 2.36MB

Thought Leader:Lucienne Cicurel, Ph.D., External Affairs Director, Debiopharm Group

Dr. Cicurel discusses trends in competition in the oncology space, best practices for partnerships, and funding for development.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Multimechanism Drugs

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 26 Jul 2007 10:52:48 PDT

Date: June 2007
Length: 00:4:26
Size: 2.02MB

Thought Leader:James S. Burns, President and CEO, EntreMed Inc.

Mr. Burns talks about the advantages of multimechanism drugs to solve distinct development challenges in the oncology arena, the complexities of drug development, and the challenges associated with running a biotechnology company.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

The State of Biotechnology in Kansas

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 26 Jul 2007 10:32:33 PDT

Date: June 2007
Length: 00:3:56
Size: 1.80MB

Thought Leader: U.S. Senator Pat Roberts, U.S. Senator, Kansas; Tom Thornton, President and CEO, Kansas Biotech Authority, and Angela Krupps, President, Kansas BIO

State representatives discuss Kansas' biotechnology initiatives — health, agro, and biofuels — and what these mean to the state's economy.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Macromolecule Development Trends

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 26 Jul 2007 10:35:31 PDT

Date: June 2007
Length: 00:6:47
Size: 3.10MB

Thought Leader:Timothy Duffy, Executive VP, Marketing and Business Development, Nastech Pharmaceutical Co.

Mr. Duffy discusses how macromolecules — peptides and protein therapeutics — are expanding opportunities for development, partnering, therapeutic focus, and delivery of compounds.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

New R&D Model

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 26 Jul 2007 10:32:58 PDT

Date: June 2007
Length: 00:12:56
Size: 5.92MB

Thought Leader: Jeff Davis, Head, Global New Business Development, and Kevin Driscoll, Ph.D., Director, Global New Technology Development, P&G Pharmaceuticals Inc.

Mr. Davis and Dr. Driscoll reveal P&G's outsourcing strategy for drug development, therapeutic areas of concentration, partnering strategies, and how the biotechnology component factors into the model.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Integrated Development Strategies

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 26 Jul 2007 10:33:37 PDT

Date: June 2007
Length: 00:6:51
Size: 3.13MB

Thought Leader: Stephen Keith Rhind, Ph.D., Senior VP, S*BIO Pte Ltd.

Dr. Rhind talks about the advantages of having integrated development capabilities, being based in Singapore in terms of patient recruitment, and the challenges involved in moving from discovery to development from a commercial perspective.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Hot Trends in the Biotech Sector

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 26 Jul 2007 10:33:54 PDT

Date: June 2007
Length: 00:4:53
Size: 2.23MB

Thought Leader: Scott Ballenger, R.Ph., President, Trial Acceleration Institute

Mr. Ballenger discusses the hot trends in the biotech sector, such as the global nature of the industry, innovation, and what the promise of the industry holds.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Leadership Development with the HBA

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 26 Jul 2007 10:34:05 PDT

Date: May 2007
Length: 00:16:27
Size: 7.53MB

Thought Leader: Cathy Kerzner, President, Healthcare Businesswomen's Association

Cathy Kerzner discusses the HBA's goals for the year, the importance of setting a personal leadership agenda, and the importance of being an HBA Rising Star, with Taren Grom Editor of PharmaVOICE. In addition, Ms. Kerzner outlines the many ways the global organization can foster career development in the life sciences. Please see the Special Feature article in the May issue of PharmaVOICE showcasing all of the 2007 HBA Rising Stars.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Industry Solutions for Improving Public Health

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 05 Jun 2007 08:49:07 PDT

Date: May 2007
Length: 00:14:57
Size: 6.84MB

Thought Leaders: Michael Ball, Ph.D., VP, Marketing and Product Management, InfoMedics, and Paul LeVine, VP, Analytical Services, InfoMedics

This episode covers several key issues regarding the role pharmaceutical companies play in the public-health sector, including the importance of communicating with stakeholders, the need to support patients through education, and where the industry, as a whole, is going.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Pharma's Expanding Role in Public Health

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 01 May 2007 14:58:16 PDT

Date: May 2007
Length: 00:14:23
Size: 6.59MB

Thought Leader: Barbara DeBuono, M.D., MPH, Senior Medical Advisor, U.S. Public Health and Policy, Pfizer Global Pharmaceuticals, Pfizer Inc.

There is no shortage of challenges regarding public health in the United States. In this Podcast episode, Dr. DeBuono discusses the impact the pharmaceutical industry can have on public health, talks about what pharma companies should be doing over the next five years, and provides some advice for developing talent in the public health sector.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

eClinical Integration

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 12 Sep 2008 08:21:12 PDT

Date: April 2007
Length: 00:11:34
Size: 5.29MB

Thought Leader: Steve Kent, CEO, ClinPhone, Nottingham, UK

New technologies will play a key role in accelerating and transforming the drug-development process. In this Podcast episode, Steven Kent, CEO of ClinPhone, discusses the challenges and solutions involved with integrating different electronic systems, the barriers to adoption, the impact of regulatory standards, and the technology trends that will have the greatest impact on clinical research.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Global Branding, Not Blanding

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 16 Apr 2007 06:01:54 PDT

Date: March 2007
Length: 00:19:24
Size: 8.88MB

Thought Leaders: Rob Rogers, Chief Creative Officer, Sudler & Hennessey, Bruno Stucchi, Global Creative Director, Sudler & Hennessey, Milan, Italy

In this Podcast episode, two advertising executives provide a creative twist as they discuss the next evolution in global pharmaceutical branding. They talk about new approaches to branding on a global scale, why brand managers should think about return on concept rather than return on investment, and ways in which the Internet is providing global marketing opportunities for brands of all sizes.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Leadership Development

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 01 May 2007 07:20:50 PDT

Date: March 2007
Length: 00:15:54
Size: 7.28MB
Thought Leader: Jonathan E. Lim, M.D., President and CEO, Halozyme Therapeutics

A career in the life sciences can be extremely rewarding. Dr. Lim shares his views and practices for finding and developing talent. He also discusses the value of interpersonal skills, and the effects of globalization on the workforce.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

EDC and After

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 01 May 2007 07:21:02 PDT

Date: March 2007
Length: 00:18:14
Size: 8.34MB
Thought Leaders: Dr. Stephen Rhys Thomas, Senior Partner, and John F. Murray, Senior Partner, Procela Partners

Based on Procela Partners' comprehensive research into the EDC landscape, Dr. Thomas and Mr. Murray provide an independent, insiders' review of the latest trends in the EDC market, including a discussion related to convergent strategies for streamlining the adoption cycle for new technologies as well as the challenges vendors and sponsors face in implementing enterprisewide systems. They also provide a provocative preview of the e-clinical landscape after EDC.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

The Challenges of Pharmacogenomics

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 01 May 2007 07:21:13 PDT

Date: 2/1/2007
Length: 00:16:17
Size: 7.45MB
Thought Leader: Brian Spear, Ph.D., Director of Genomic and Proteomic Technologies, Global Pharmaceutical Research and Development — Abbott

Pharmacogenomics is a serious science that has the potential to revolutionize the life sciences. Dr. Spear discusses the myths, misconceptions, trends, and challenges associated with pharmacogenomics and personalized medicine. He also talks about the future of this groundbreaking science.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

The Benefits of a Proactive Compliance Program

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 11 Jan 2007 07:15:43 PST

Date: 1/11/2007
Length: 00:15:24
Size: 7.05MB

Thought Leader: Eric Siegel, VP, Deputy General Counsel, and Chief Compliance Officer, Cephalon Inc.

Discover how to overcome the challenges related to implementing a corporate-wide compliance program as well how compliance programs can help companies achieve their business objectives. These, and other topics, are covered in this informative episode.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Compliance Training Options — Build vs. Buy

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 03 Jan 2007 07:16:33 PST

Date: 12/29/2006
Length: 00:12:17
Size: 5.62MB
Thought Leader: Peter Sandford, Executive VP, NXLevel

With myriad industry, state, and federal regulations and guidances, compliance training has never been more important. Technology provides an efficient delivery mechanism for a company's training courses. This episode outlines the strengths and weaknesses of custom-built and off-the-shelf training solutions, as well as a hybrid approach.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Salesforce Compliance Strategies and Tactics

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 03 Jan 2007 07:16:23 PST

Date: 12/21/2006
Length: 00:20:02
Size: 9.16MB
Thought Leader: William C. Bertrand Jr., Senior VP, General Counsel, Corporate Compliance, MedImmune Inc.

Sales and marketing compliance is paramount in the pharmaceutical and biotechnology industries and staying current with ever-changing regulations is mandatory. Keeping the salesforce in step with the company's compliance policies is a never-ending process. This episode features best practices, tips, and lessons from a true industry expert.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Integrated Data Management and EDC Solutions

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 03 Jan 2007 07:14:44 PST

Date: 12/11/2006
Length: 00:21:30
Size: 9.84MB

Thought Leader: Glen de Vries, Cofounder and Chief Technology Officer, Medidata Solutions Worldwide

Clinical trials can benefit greatly from standardization, integrated data management, and the right electronic data capture solution. This episode covers a variety of issues that can help you achieve better ROI from the data management tools being used in clinical trials.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Agile Clinical Trials and the Use of Real-Time Data

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 03 Jan 2007 07:15:29 PST

Date: 11/7/2006
Length: 00:18:14
Size: 8.34MB

Thought Leader: John Hudak, MBA, President and Founder, Criterium Inc.

How does real-time data improve the agility of clinical trials? How can the process be improved through technology? What are the benefits of using real-time data? Are there any obstacles to be overcome? What is the impact of real-time data on sites, sponsors, and CROs? Learn the answers to these and other questions in this informative Podcast episode.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Evolving from R&D to Commercialization

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 21 Nov 2006 10:53:35 PST

Date: 11/8/2006
Length: 00:15:40
Size: 7.17MB

Thought Leader: Richard W. Pascoe, VP and Chief Commercial Officer, Ariad Pharmaceuticals Inc.

Transforming a company from an R&D organization into a commercialization entity can be a daunting undertaking. You'll learn about the building blocks of a commercial platform, strategic planning, inevitable obstacles, and best practices that can be used on the journey.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

New Marketing Paradigm for Patient-Physician Communications

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 07 Nov 2006 11:58:42 PST

Date: 10/27/2006
Length: 00:17:20
Size: 7.93MB

Thought Leaders: Jeanne Zucker, VP, Strategic Business Development, and Paul LeVine, VP, Analytic Services, InfoMedics Inc.

Pharmaceutical companies must radically change the way they market to patients and physicians. By creating an environment of collaboration, including more communications between patients and physicians, improved treatment outcomes are possible, while maintaining compliance.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Structuring a Successful Global Marketing Campaign

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 07 Nov 2006 11:44:55 PST

Date: 10/13/2006
Length: 00:17:52
Size: 8.18MB

Thought Leader: Phil Deschamps, President and CEO, GSW Worldwide

Is a global campaign the right move for your brand? Is your organization set up to successfully launch a global initiative? This Podcast illuminates the necessary components to take a brand global and at the same time avoid some of the common pitfalls that can potentially damage a global campaign.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Electronic Submissions and eCTD Challenges

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 18 Oct 2006 07:01:13 PDT

Date: 10/11/2006
Length: 00:15:08
Size: 6.93MB

Thought Leader: John Lawrie, VP, Process Solutions — Octagon Research Solutions Inc.

Submitting drug applications electronically has many advantages, and the industry is progressively adopting this practice as its standard. Learn how to navigate the complex waters of esubs and developing eCTD capabilities.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Marketing to Managed Care

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 18 Oct 2006 07:01:47 PDT

Date: 10/3/2006
Length: 00:13:46
Size: 6.4MB

Thought Leader: Mark Zitter, Founder and CEO, The Zitter Group

While DTC and physician marketing get all the attention, managed care often gets left behind. Learn why it's so important for manufacturers to market to payers and understand the function of the P&T Committee. Hear about the strategies and tactics that deliver the most impact for your brand.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

The Silent Exam Room

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 18 Oct 2006 07:02:38 PDT

Date: 9/21/2006
Length: 00:28:44
Size: 13.1MB

Thought Leaders:
Stanley Wulf, M.D., VP, Chief Medical Officer, InfoMedics Inc.
Paul LeVine, VP, Analytic Services, InfoMedics Inc.

Do physicians and patients ever really talk anymore? In these go-go times, this relationship has broken down, and patient care suffers. Find out how to improve physician-patient communications and what that means to physicians, patients, and pharmaceutical companies.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Overcoming Marketing Challenges

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 18 Oct 2006 06:46:01 PDT

Date: 9/11/2006
Length: 00:12:06
Size: 5.54MB

Thought Leader: Lauren Coyle, Senior Product Manager, Otsuka America Pharmaceutical Inc.

Pharmaceutical marketing has never been more complex. In this episode, we tackle six important issues from the product manager's perspective.

Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Patient Safety and IRB Accreditation

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 18 Oct 2006 06:45:12 PDT

Date: 8/25/2006
Length: 00:11:55
Size: 5.45MB

Thought Leader: Lynn A. Meyer, CIP, CIM, President, IntegReview Ethical Review Board

Does an accredited Institutional Review Board (IRB) improve patient safety? This podcast covers the pros and cons of accreditation and some of the issues involved in patient safety and trial efficiency during clinical trials on humans.

Full podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Novartis' Forward-thinking Training Strategy

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 18 Oct 2006 06:48:20 PDT

Date: 07/12/2006
Length: 00:20:04
Size: 9.18MB

Thought Leader: John Talanca Jr., Head, Learning Technologies — Novartis Pharmaceuticals Corporation

At Novartis, learning is a respected part of the workday for sales reps. Learn how to make it a reality in your company. E-learning and other important technologies are also discussed. Hear about Novartis' training outsourcing strategy, and discover some emerging trends in training.

Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Pharma's Contribution to Innovations in Healthcare

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 18 Oct 2006 06:49:04 PDT

Date: 7/13/2006
Length: 00:18:55
Size: 8.65MB

Thought Leader: Leslie Williams, Founder, President and CEO — Ventaira Pharmaceuticals

Ventaira CEO Leslie Williams provides keen insights into several pharma-related topics, including promising areas in medicine, challenges in clinical development, innovations in inhalation technologies, a look at the pharma industry in 10 years, maximizing partnerships with pharma & biotech companies, the pros and cons of being privately held, and how pharma fits into the healthcare spectrum.

Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Optimizing Pharmaceutical Marketing

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 18 Oct 2006 06:49:49 PDT

Date: 7/11/2006
Length: 00:13:11
Size: 6.03MB

Thought Leader: David Zaritsky, Managing Director, Pharmaceutical Markets, Harte-Hanks Inc.

Learn more about the changing landscape of pharmaceutical marketing. This episode features a compelling discussion on maximizing total prescriptions through customer optimization and non-manpowered selling.

Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Innovative Technologies in Clinical Research

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 18 Oct 2006 06:50:42 PDT

Date: 7/10/2006
Length: 00:35:25
Size: 16.2MB

Thought Leader: Anthony J. Costello, Founder and VP, Product Development and Data, Nextrials Inc.

Discover the newest technologies in clinical research, including a discussion on the ROI of technology implementations and industry adoption rates. Also covered are Electronic Data Collection, electronic health records, industry standards, and regulatory guidances.

Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Oncolytics Biotech Provides Insider Insights into Clinical Research

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 18 Oct 2006 06:51:07 PDT

Date: 7/11/2006
Length: 00:15:48
Size: 7.24MB

Thought Leader: Brad Thompson, Ph.D., President and CEO — Oncolytics Biotech Inc.

The CEO of Oncolytics Biotech speaks on a variety of topics, including challenges in clinical research and patient recruitment in oncological studies.

Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Innovations in Clinical Development for Biotechnology

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 18 Oct 2006 06:52:10 PDT

Date: 7/10/2006
Length: 00:19:38
Size: 8.99MB

Thought Leader: Russell H. Ellison, M.D., M.Sc., VP, Clinical Development — Fibrogen Inc.

Learn about obstacles in the development of clinical programs, drug development models, hot areas in scientific development, emerging trends in biotechnology, and an expert's view of the future in the industry...

Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Roche Pharma Partnering: Beyond the Deal

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 18 Oct 2006 07:00:43 PDT

Date: 04/11/06
Length: 00:17:02
Size: 7.9MB

Thought Leader: Dr. Peter Hug, Executive VP, Pharma Partnering — F. Hoffman-La Roche Ltd.
Find out what pharmaceutical giant Roche looks for in partnering opportunities, as well as views on personalized medicine and venture capitalists...

Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

How Consumer Web Traffic May Impact Revenue for Top Selling Drugs

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 12 Sep 2008 08:33:49 PDT

Date: 03/27/06
Length: 00:18:15
Size: 8.5MB

Thought Leader: Daniel Limbach, Managing Editor — PharmaVOICE VIEW magazine

Do the top selling drugs have the highest traffic Websites? Is there a connection? We study this premise using recent traffic data and drug sales figures. You might be surprised what we discovered...

Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Evolution of a Biopharmaceutical Company: Nektar Therapeutics

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 18 Oct 2006 06:59:49 PDT

Date: 04/11/06
Length: 00:11:48
Size: 5.5MB

Thought Leader: Hoyoung Huh, M.D. Ph.D., Senior VP, Business Development — Nektar Therapeutics

Nektar has crossed the chasm from a drug-delivery-technology company to a product-development company. Dr. Huh describes how they made the transition, and what to look for from them in the future.

Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Ohio - An Emerging Biotech Region

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 18 Oct 2006 06:58:36 PDT

Date: 04/10/06
Length: 00:05:46
Size: 2.7MB

Thought Leader: Bob Taft, Governor — State of Ohio

When listing the top biotech regions in the U.S., Ohio is not always included with renown biotech states such as California, Massachusetts, or even Wisconsin. Governor Taft explains how Ohio is becoming a top biotech region...

Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Billionaire Lifting NC to Top of Biotechnology Industry

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 18 Oct 2006 06:58:07 PDT

Date: 04/10/06
Length: 00:23:57
Size: 11MB

Thought Leader: David Murdock, Owner — Castle & Cooke Inc. and Dole Food Company Inc.

Many billionaires leave their legacy through endowments and charitable donations. David Murdock is taking a hands-on approach, and building a state-of-the-art biotech campus with over $1 billion of his own money. Mr. Murdock shares his vision.

Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Innovations in Drug Packaging and Formulations

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 18 Oct 2006 06:57:37 PDT

Date: 04/06/06
Length: 00:18:49
Size: 8.8MB

Thought Leader: Joel Tune, General Manager — Baxter BioPharma Solutions

Baxter Biopharma Solutions knows outsourcing — especially when it comes to syringes and vials. Now they are into nanotechnology and other new technologies that extend the life of a compound. Find out more about this division of Baxter Healthcare.

Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Personalizing Patient Compliance

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 18 Oct 2006 06:57:08 PDT

Date: 04/17/06
Length: 00:34:45
Size: 16.2MB

Thought Leader: Kevin Wildenhaus Ph.D., Director of Behavioral Science — HealthMedia Inc.

In this compelling podcast, Kevin Wildenhaus outlines his "FIRE and ICE" program. Find out what it stands for and then apply it to your work.

Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

One-Stop Shopping for the Life Sciences

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 18 Oct 2006 06:56:35 PDT

Date of recording: 04/09/06
Length: 00:13:27
Size: 6.3MB

Featured Thought Leader: Greg Lucier, CEO, Invitrogen

Is there a one-stop shop for biotechnology? Find out how Invitrogen's Web-based initiatives and outsourcing services contributed to their rapid growth and make them a company to watch in 2006. Recorded at the BIO 2006 conference.

Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.